Wenwei Hu

发表

MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

W. Choi, J. Winter, M. Piris, 2013, Blood.

Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation

Qin Li, Wenwei Hu, Jie-Min Zhao, 2022, Frontiers in Immunology.

LncRNA HCG18 promotes M2 macrophage polarization to accelerate cetuximab resistance in colorectal cancer through regulating miR-365a-3p/FOXO1/CSF-1 axis.

Wenwei Hu, Jie-Min Zhao, X. Ni, 2022, Pathology, research and practice.

LIF negatively regulates tumor suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers

K. Young, Juan Liu, Cen Zhang, 2014, Nature Communications.

TP53 Gain-of-Function and Non–Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal Cancer

L. Habel, M. Pan, S. Alexeeff, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single-cell transcriptome analysis of tumor immune microenvironment characteristics in colorectal cancer liver metastasis

Y. Wang, Wenwei Hu, Hao Huang, 2022, Annals of translational medicine.

Lycorine Promotes Autophagy and Apoptosis via TCRP1/Akt/mTOR Axis Inactivation in Human Hepatocellular Carcinoma

Yi Zhang, Lifeng Han, Haiyang Yu, 2017, Molecular Cancer Therapeutics.

A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.

X. Chen, Xiaolong Wang, Ning Zhang, 2014, Gene.

Role of VEGF-A/C and CCR-7 in the enhanced metastasis of A549 cells induced by 2 and 4 Gy X-rays in vitro and in vivo

Xiu-jun Song, Wenwei Hu, Qisheng Jiang, 2014, Science China Technological Sciences.

Advances in adoptive cellular therapy for colorectal cancer: a narrative review

Wenwei Hu, Xing Yi, 2022, Annals of translational medicine.

A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.

X. Chen, Xiaolong Wang, Ning Zhang, 2014, Gene.